Biliary Tract Cancers

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2016-03-03
Clinical Trial Update: A Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract Cancers [Phase 2]
Phase IIa trial of trametinib monotherapy for biliary tract cancers completed with results posted.